Serological evidence of Rift Valley fever virus infection among domestic ruminant herds in Uganda.
ELISA
Epidemics
Rift Valley fever virus
Sero-surveillance
Journal
BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759
Informations de publication
Date de publication:
13 Apr 2021
13 Apr 2021
Historique:
received:
03
04
2020
accepted:
31
03
2021
entrez:
14
4
2021
pubmed:
15
4
2021
medline:
26
8
2021
Statut:
epublish
Résumé
Prior to the first recorded outbreak of Rift Valley fever (RVF) in Uganda, in March 2016, earlier studies done until the 1970's indicated the presence of the RVF virus (RVFV) in the country, without any recorded outbreaks in either man or animals. While severe outbreaks of RVF occurred in the neighboring countries, none were reported in Uganda despite forecasts that placed some parts of Uganda at similar risk. The Ministry of Agriculture, Animal Industry and Fisheries (MAAIF) undertook studies to determine the RVF sero-prevalence in risk prone areas. Three datasets from cattle sheep and goats were obtained; one from retrospective samples collected in 2010-2011 from the northern region; the second from the western region in 2013 while the third was from a cross-sectional survey done in 2016 in the south-western region. Laboratory analysis involved the use of the Enzyme Linked Immunosorbent Assays (ELISA). Data were subjected to descriptive statistical analyses, including non-parametric chi-square tests for comparisons between districts and species in the regions. During the Yellow Fever outbreak investigation of 2010-2011 in the northern region, a total sero-prevalence of 6.7% was obtained for anti RVFV reacting antibodies (IgG and IgM) among the domestic ruminant population. The 2013 sero-survey in the western region showed a prevalence of 18.6% in cattle and 2.3% in small ruminants. The 2016 sero-survey in the districts of Kabale, Kanungu, Kasese, Kisoro and Rubirizi, in the south-western region, had the respective district RVF sero-prevalence of 16.0, 2.1, 0.8, 15.1and 2.7% among the domestic ruminants combined for this region; bovines exhibited the highest cumulative sero-prevalence of 15.2%, compared to 5.3 and 4.0% respectively for sheep and goats per species for the region. The absence of apparent outbreaks in Uganda, despite neighboring enzootic areas, having minimal restrictions to the exchange of livestock and their products across borders, suggest an unexpected RVF activity in the study areas that needs to be unraveled. Therefore, more in-depth studies are planned to mitigate the risk of an overt RVF outbreak in humans and animals as has occurred in neighboring countries.
Sections du résumé
BACKGROUND
BACKGROUND
Prior to the first recorded outbreak of Rift Valley fever (RVF) in Uganda, in March 2016, earlier studies done until the 1970's indicated the presence of the RVF virus (RVFV) in the country, without any recorded outbreaks in either man or animals. While severe outbreaks of RVF occurred in the neighboring countries, none were reported in Uganda despite forecasts that placed some parts of Uganda at similar risk. The Ministry of Agriculture, Animal Industry and Fisheries (MAAIF) undertook studies to determine the RVF sero-prevalence in risk prone areas. Three datasets from cattle sheep and goats were obtained; one from retrospective samples collected in 2010-2011 from the northern region; the second from the western region in 2013 while the third was from a cross-sectional survey done in 2016 in the south-western region. Laboratory analysis involved the use of the Enzyme Linked Immunosorbent Assays (ELISA). Data were subjected to descriptive statistical analyses, including non-parametric chi-square tests for comparisons between districts and species in the regions.
RESULTS
RESULTS
During the Yellow Fever outbreak investigation of 2010-2011 in the northern region, a total sero-prevalence of 6.7% was obtained for anti RVFV reacting antibodies (IgG and IgM) among the domestic ruminant population. The 2013 sero-survey in the western region showed a prevalence of 18.6% in cattle and 2.3% in small ruminants. The 2016 sero-survey in the districts of Kabale, Kanungu, Kasese, Kisoro and Rubirizi, in the south-western region, had the respective district RVF sero-prevalence of 16.0, 2.1, 0.8, 15.1and 2.7% among the domestic ruminants combined for this region; bovines exhibited the highest cumulative sero-prevalence of 15.2%, compared to 5.3 and 4.0% respectively for sheep and goats per species for the region.
CONCLUSIONS
CONCLUSIONS
The absence of apparent outbreaks in Uganda, despite neighboring enzootic areas, having minimal restrictions to the exchange of livestock and their products across borders, suggest an unexpected RVF activity in the study areas that needs to be unraveled. Therefore, more in-depth studies are planned to mitigate the risk of an overt RVF outbreak in humans and animals as has occurred in neighboring countries.
Identifiants
pubmed: 33849526
doi: 10.1186/s12917-021-02867-0
pii: 10.1186/s12917-021-02867-0
pmc: PMC8045185
doi:
Substances chimiques
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
157Subventions
Organisme : Defense Threat Reduction Agency
ID : HDTRA1-14-C-0104
Organisme : European PANDORA-ID-NET project
ID : EDCTP2
Références
Emerg Infect Dis. 2002 Dec;8(12):1415-20
pubmed: 12498657
Am J Trop Med Hyg. 2010 Aug;83(2 Suppl):43-51
pubmed: 20682905
Intervirology. 1980;14(3-4):125-43
pubmed: 6165702
Am J Trop Med Hyg. 2019 Mar;100(3):659-671
pubmed: 30675833
Br J Exp Pathol. 1949 Feb;30(1):1-16
pubmed: 18128091
Infect Ecol Epidemiol. 2015 Jul 31;5:28024
pubmed: 26234531
Am J Trop Med Hyg. 2010 Aug;83(2 Suppl):58-64
pubmed: 20682907
Vet Rec. 1979 Aug 11;105(6):124-5
pubmed: 505918
J S Afr Vet Assoc. 2017 Jan 20;88(0):e1-e5
pubmed: 28240033
Cad Saude Publica. 2001;17 Suppl:133-40
pubmed: 11426274
Ann Inst Pasteur Virol. 1988 Jul-Sep;139(3):307-8
pubmed: 3207509
Ann Microbiol (Paris). 1974 Jul-Aug;125B(1):107-18
pubmed: 4157115
Arch Virol. 2017 Aug;162(8):2505-2538
pubmed: 28434098
Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):851-4
pubmed: 2559514
Am J Trop Med Hyg. 1988 Dec;39(6):617-31
pubmed: 2462795
Br J Exp Pathol. 1948 Apr;29(2):107-21
pubmed: 18868961
J Vet Med. 2018 Jun 28;2018:4956378
pubmed: 30050953
J Virol. 2011 Jul;85(13):6162-7
pubmed: 21507967
J Virol Methods. 2005 Jul;127(1):10-8
pubmed: 15893560
Lancet. 1983 Mar 19;1(8325):641
pubmed: 6131312
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):938-943
pubmed: 28096420
Onderstepoort J Vet Res. 2019 Oct 10;86(1):e1-e5
pubmed: 31714136
Microb Pathog. 1987 Apr;2(4):283-93
pubmed: 3509859
Vaccines (Basel). 2017 Sep 19;5(3):
pubmed: 28925970